Previous study explored the TMSB10 promoted glioma progression via YAP1/AKT/ERK1/2, but we explored the TMSB10 promoted glioma progression via IL6/JAK/STAT3 signaling pathway. This evidence concerns the gene IL6 and central nervous system cancer.